| Sumatriptan | Ki | 8.5 [1] |
| Serotonin | IC50 | 3.0 [1] |
| Serotonin | Ki | 5.06 [1] |
| GR-127935 | IC50 | 52.0 [1] |
| Rizatriptan | IC50 | 11.0 [1], 79.43 [2] |
| Rizatriptan | Ki | 4.3 [1], 13.5 [2], 40.0 [3] |
| 6-((1-(2-((2-Methylquinolin-5-yl)oxy)ethyl)piperidin-4-yl)methyl)-2H-1,4-benzoxazin-3(4H)-one | Ki | 1.58 [1] |
| 3-(2-Pyrrolidin-1-ylethyl)-5-(1,2,4-triazol-4-yl)-1H-indole | IC50 | 3.1 [1], 3.4 [2] |
| 3-[3-(4-Benzylpiperazino)propyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 0.1 [1], 0.14 [2], 0.2 [3] |
| N-Benzyl-1-[(3S)-1-[2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethyl]pyrrolidin-3-yl]methanamine | IC50 | 0.5 [1], 0.6 [2] |
| Ergotamine | Ki | 0.8 [1], 2.2 [2], 4.3 [3], 6.0 [4] |
| Zolmitriptan | IC50 | 2.82 [1] |
| Zolmitriptan | Ki | 0.76 [1], 0.92 [2], 4.0 [3] |
| CID 9847194 | IC50 | 0.9 [1] |
| CID 9847194 | Ki | 0.9 [1] |
| 6-[2-[4-(2-Methylquinolin-5-yl)piperazin-1-yl]ethyl]-4H-1,4-benzoxazin-3-one | Ki | 0.16 [1], 0.2 [2], 0.5 [3] |
| 5-(4H-1,2,4-Triazole-4-yl)-3-[3-[4-(methylbenzylamino)piperidino]propyl]-1H-indole | IC50 | 2.1 [1], 2.2 [2] |
| 1-[4-[2-Methylphenyl]piperazin-1-yl]-2-[[3-(2-aminoethyl)-1H-indol-5-yl]oxy]ethanone | Ki | 0.8 [1], 0.87 [2], 2.08 [3], 2.1 [4] |
| 1-(4-Phenylpiperazin-1-yl)-2-[[3-(2-aminoethyl)-1H-indol-5-yl]oxy]ethanone | Ki | 0.4 [1], 0.6 [2], 1.2 [3] |
| SB 224289 | IC50 | 1000.0 [1] |
| SB 224289 | Ki | 260.0 [1], 501.19 [2] |
| 4-Fluoro-N-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]benzamide | Ki | 137.0 [1], 430.0 [2] |
| 5-(4H-1,2,4-Triazole-4-yl)-3-[3-(4-benzylpiperidino)propyl]-1H-indole | IC50 | 0.3 [1], 0.35 [2] |
| 3-[3-(4-Fluoro-4-benzylpiperidino)propyl]-5-(4H-1,2,4-triazole-4-yl)-1H-indole | IC50 | 0.9 [1], 1.0 [2] |
| N,N-Dimethyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine | IC50 | 660.69 [1] |
| N-(3-(1-(2-(2-Methylquinolin-5-yloxy)ethyl)piperidin-4-ylmethyl)phenyl)methanesulfonamide | Ki | 0.5 [1] |
| 8-[2-[4-(2-Methylquinolin-5-yl)piperazin-1-yl]ethyl]-4H-1,4-benzoxazin-3-one | Ki | 0.05 [1] |
| 4-Methyl-8-[2-[4-(2-methylquinolin-5-yl)piperazin-1-yl]ethyl]-1,4-benzoxazin-3-one | Ki | 0.1 [1], 0.32 [2] |
| 1-[2-[4-(6-Fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-yl]ethyl]-3,4-dihydro-1H-isochromene-6-carboxamide | Ki | 8.0 [1], 56.0 [2] |
| N,N-Dimethyl-2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethanamine | IC50 | 0.3 [1] |
| 4-Methyl-6-[2-[4-(2-methylquinolin-5-yl)piperazin-1-yl]ethyl]-1,4-benzoxazin-3-one | Ki | 0.1 [1], 0.32 [2] |
| 1-[4-[4-(Acetylamino)phenyl]piperazin-1-yl]-2-[[3-(2-aminoethyl)-1H-indol-5-yl]oxy]ethanone | Ki | 1.4 [1], 1.7 [2], 2.8 [3] |
| Trifluoro-methanesulfonic acid 3-(2-dimethylamino-ethyl)-1H-indol-5-yl ester | IC50 | 8.4 [1] |
| Trifluoro-methanesulfonic acid 3-(2-dimethylamino-ethyl)-1H-indol-5-yl ester | Ki | 3.2 [1], 30.0 [2] |
| Trifluoro-methanesulfonic acid 3-(2-diethylamino-ethyl)-1H-indol-5-yl ester | IC50 | 21.0 [1] |
| Trifluoro-methanesulfonic acid 3-(2-diethylamino-ethyl)-1H-indol-5-yl ester | Ki | 12.0 [1], 29.0 [2] |
| Trifluoro-methanesulfonic acid 3-(2-dipropylamino-ethyl)-1H-indol-5-yl ester | IC50 | 170.0 [1] |
| Trifluoro-methanesulfonic acid 3-(2-dipropylamino-ethyl)-1H-indol-5-yl ester | Ki | 36.0 [1], 190.0 [2] |
| 8-OH-Dpat | Ki | 115.0 [1], 164.0 [2] |
| Ketanserin | IC50 | 260.0 [1], 270.0 [2] |
| Mianserin | IC50 | 380.19 [1] |
| Tryptamine | Ki | 23.0 [1], 61.0 [2] |
| Tolazoline | Ki | 10000.0 [1] |
| 5-Methoxytryptamine | Ki | 4.1 [1], 5.4 [2] |
| N,N-Dimethyl-5-methoxytryptamine | IC50 | 49.0 [1] |
| N,N-Dimethyl-5-methoxytryptamine | Ki | 20.0 [1] |
| Xylometazoline | Ki | 0.7 [1] |
| 1-Naphthylpiperazine | Ki | 6.18 [1], 6.2 [2] |
| (7R)-7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol | Ki | 164.0 [1], 638.0 [2] |
| 3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide | Ki | 0.3 [1], 104.0 [2] |
| 2-Ethyl-5-methoxy-N,N-dimethyltryptamine | IC50 | 1400.0 [1] |
| 2-Ethyl-5-methoxy-N,N-dimethyltryptamine | Ki | 290.0 [1] |
| N,N-Diallyl-5-methoxytryptamine | Ki | 158.49 [1], 10000.0 [2] |
| (1S)-1-[2-[4-(4-Methoxyphenyl)piperazin-1-yl]ethyl]-N-methyl-3,4-dihydro-1H-isochromene-6-carboxamide | Ki | 0.9 [1] |
| CID 9870500 | Ki | 1.0 [1], 2.0 [2] |
| N,N-Di-n-propylserotonin | IC50 | 820.0 [1] |
| N,N-Dipropyl-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-amine | Ki | 39.0 [1], 40.0 [2] |
| Dipropyl-(S)-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-yl-amine | Ki | 440.0 [1], 441.0 [2] |
| Dipropyl-(R)-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-yl-amine | Ki | 16.0 [1] |
| 5-Chloro-N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-3-methyl-1-benzothiophene-2-sulfonamide | Ki | 199.53 [1] |
| 2-Methyl-5-(2-(4-(quinolin-8-ylmethyl)piperazin-1-yl)ethoxy)quinoline | Ki | 0.79 [1] |
| 3-[2-Fluoro-3-(4-benzylpiperidino)propyl]-5-(4H-1,2,4-triazole-4-yl)-1H-indole | IC50 | 0.9 [1], 0.95 [2] |
| 2-(Dipropylamino)-8-[(trifluoromethylsulfonyl)-oxy]tetralin | Ki | 12.0 [1], 127.0 [2] |
| Trifluoro-methanesulfonic acid 7-propylamino-5,6,7,8-tetrahydro-naphthalen-1-yl ester | Ki | 15.0 [1], 169.0 [2] |
| 2-(2,6-Dimethyl-benzyl)-4,5-dihydro-1H-imidazole | Ki | 2210.0 [1] |
| 4-[2-Amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]benzonitrile | Ki | 120.0 [1] |
| 2-(Dimethylamino)-N-[3-[[1-[2-(2-methylquinolin-5-yl)oxyethyl]piperidin-4-yl]methyl]phenyl]acetamide | Ki | 1.0 [1] |
| Methyl 1-[3-[[2,6-dimethyl-5-(methylcarbamoyl)-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | Ki | 5000.0 [1], 8840.0 [2] |
| 1-(17-Chloro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine | IC50 | 134.9 [1] |
| N-Benzyl-N-methyl-1-[(3S)-1-[2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethyl]pyrrolidin-3-yl]methanamine | IC50 | 0.7 [1] |
| 3-[3-[4-Fluoro-4-(3-fluorophenethyl)piperidino]propyl]-5-(4H-1,2,4-triazole-4-yl)-1H-indole | IC50 | 0.7 [1], 0.75 [2] |
| 3-[3-[4-(2-Fluorophenethyl)piperazino]propyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 0.5 [1], 0.6 [2] |
| 3-[3-[4-(4-Fluorophenethyl)piperazino]propyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 0.8 [1] |
| 3-[2-Fluoro-3-[4-(3-fluorophenethyl)piperazino]propyl]-5-(4H-1,2,4-triazole-4-yl)-1H-indole | IC50 | 3.5 [1], 3.7 [2] |
| Benzyl-{1-[3-(5-[1,2,4]triazol-4-yl-1H-indol-3-yl)-propyl]-piperidin-4-yl}-amine | IC50 | 4.6 [1], 4.8 [2] |
| 3-[2-(4-Methylpiperazino)ethyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 134.0 [1], 140.0 [2] |
| (3R)-N-Benzyl-N-methyl-1-[2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethyl]pyrrolidin-3-amine | IC50 | 37.0 [1], 38.0 [2] |
| 3-[3-(4-Phenethylpiperazino)propyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 1.4 [1] |
| (R)-beta-[[1-[3-[5-(4H-1,2,4-Triazol-4-yl)-1H-indol-3-yl]propyl]piperidin-4-yl]amino]benzeneethanol | IC50 | 1.3 [1] |
| 3-(3-Piperidinopropyl)-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 24.0 [1] |
| 3-[2-((R)-3-Benzyloxymethyl-pyrrolidin-1-yl)-ethyl]-5-[1,2,4]triazol-4-yl-1H-indole | IC50 | 2.3 [1] |
| N-[(1R)-1-Phenylethyl]-1-[3-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]piperidin-4-amine | IC50 | 0.35 [1], 0.4 [2] |
| N-Benzyl-N-methyl-1-[1-[3-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]piperidin-4-yl]methanamine | IC50 | 0.9 [1], 0.95 [2] |
| Benzyl-{(R)-1-[2-(5-[1,2,4]triazol-4-yl-1H-indol-3-yl)-ethyl]-pyrrolidin-3-ylmethyl}-amine | IC50 | 1.6 [1] |
| N-[4-[2-[4-[3-[5-(1,2,4-Triazol-4-yl)-1H-indol-3-yl]propyl]piperazin-1-yl]ethyl]phenyl]acetamide | IC50 | 1.3 [1] |
| 2-(5-((4-((3-(2-Aminoethyl)-1H-indol-5-yloxy)methyl)phenyl)methoxy)-1H-indol-3-yl)ethanamine | Ki | 0.11 [1] |
| 2-(5-(2-(8-(4-Methylpiperazin-1-yl)naphthalen-2-yloxy)ethoxy)-1H-indol-3-yl)ethanamine | Ki | 0.4 [1] |
| (3R,4S)-N-Benzyl-3-fluoro-N-methyl-1-[3-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]piperidin-4-amine | IC50 | 2.2 [1], 12.0 [2] |
| 3-(2-Piperidinoethyl)-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 200.0 [1] |
| 1H-Indole-3-ethanamine, N,N'-dimethyl-5-(phenylmethoxy)- | IC50 | 25.0 [1], 76.0 [2] |
| 3-[3-[4-(3,4-Difluorophenethyl)piperazino]propyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 0.9 [1], 1.0 [2] |
| 2-(4-Bromo-2,6-dimethyl-benzyl)-4,5-dihydro-1H-imidazole | Ki | 74.0 [1] |
| 3-[2-Fluoro-3-[4-(methylbenzylamino)piperidino]propyl]-5-(4H-1,2,4-triazole-4-yl)-1H-indole | IC50 | 5.4 [1] |
| 1-Methyl-2-(2,6-dimethyl-4-tert-butylbenzyl)-2-imidazoline | Ki | 86.0 [1] |
| 1-[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]-N-[[4-[[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methylsulfonyl-methylamino]methyl]phenyl]methyl]-N-methylmethanesulfonamide | Ki | 0.89 [1] |
| N,N-Dimethyl-2-(5-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-3-yl)ethanamine | Ki | 8.0 [1] |
| 3-[2-((R)-3-Benzyloxy-pyrrolidin-1-yl)-ethyl]-5-[1,2,4]triazol-4-yl-1H-indole | IC50 | 6.3 [1], 23.0 [2] |
| 3-[3-(4-Methylpiperazino)propyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | IC50 | 33.0 [1], 35.0 [2] |